This is the authors' abstract. We don't add key points for this paper.
We extended our previous studies based on the design of 1-[(1H-indol-5-ylmethyl)amino]-2-phenyl-3-(1H-1,2,4-triazol-1-yl)propan-2-ols as antifungal agents toward the identification of new indol-3-ylmethylamino derivatives. The majority of these compounds exhibited antifungal activity against a Candida albicans strain (minimum inhibitory concentrations ranging from 199.0 to 381.0 ng/mL) suggesting an inhibition of 14α-demethylase by sterol analysis studies, but are weaker inhibitors compared to their indol-5-ylmethylamino analogs.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Guillon et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: